Funding Early Innovation

MS Ventures invests in early stage companies that develop the next generation technologies and products to serve unmet medical need and improve patient outcomes.

Innovative Science. Strategic Insights.

Investing in innovation to develop novel technologies and products to better serve future healthcare needs.

Strategic Venture Capital

We work closely with portfolio companies to optimally position their assets towards strategic partners.

Listen to an interview with Roel

Roel Bulthuis, Head of MS Ventures, speaks about MS Ventures, and gives insight in what he expects to come in the next 12 months.

Interview with Roel Bulthuis
 

Investing in Innovation

STEFAN OSCHMANN

Stefan Oschmann
"Strategic investments in external innovation are a key component of our strategy. MS Ventures demonstrates our commitment to create long term relationships with and tap into the innovative entrepreneurial spirit of biotech companies."

Stefan Oschmann
Member of the Executive Board of Merck KGaA, Darmstadt, Germany 
and Head of the Pharmaceuticals Business of the Merck KGaA

SUSAN JANE HERBERT

Susan Jane Herbert
"We are proud of our strong track record of establishing fruitful collaborative relations with external partners aiming to develop the next generation of therapies. MS Ventures allows us to establish those relations early on to facilitate broader collaborations as technologies mature."

Susan Jane Herbert
EVP, Head of Global Business Development and Alliance Management, 
Biopharmaceutical division of Merck KGaA, Darmstadt, Germany